scholarly journals Endoscopic Ultrasound-Guided Hepaticogastrostomy Is Effective for Repeated Recurrent Cholangitis after Surgery: Two Case Reports

2018 ◽  
Vol 2018 ◽  
pp. 1-3 ◽  
Author(s):  
Akihiro Matsumi ◽  
Hironari Kato ◽  
Yousuke Saragai ◽  
Sho Mizukawa ◽  
Saimon Takada ◽  
...  
Keyword(s):  
Endoscopic Ultrasound ◽  
Case Reports ◽  
Metallic Stents ◽  
Anastomotic Stenosis ◽  
Metallic Stent ◽  
Efficacy And Safety ◽  
Ultrasound Guided ◽  
Biliary Stenosis ◽  
Double Balloon Endoscopy ◽  
Covered Metallic Stent

We report the cases of two patients who underwent endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) using metallic stents (MS) for recurrent cholangitis due to benign biliary stenosis. The patients had repeatedly undergone double-balloon endoscopy and anastomotic stenosis. Thus, EUS-HGS was performed. The procedures were successful, and placement of a covered metallic stent (C-MS) relieved cholangitis. The occurrence of cholangitis was subsequently considerably reduced. For patients with postoperative recurrent cholangitis, EUS-HGS with MS should be considered because of its efficacy and safety.

Clinical Outcome of Endoscopic Ultrasound-Guided Liver Abscess Drainage Using Self-Expandable Covered Metallic Stent (with Video)

2015 ◽  
Vol 61 (1) ◽  
pp. 303-308 ◽  
Author(s):  
Takeshi Ogura ◽  
Daisuke Masuda ◽  
Onda Saori ◽  
Takagi Wataru ◽  
Tatsushi Sano ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Liver Abscess ◽  
Endoscopic Ultrasound ◽  
Metallic Stent ◽  
Ultrasound Guided ◽  
Abscess Drainage ◽  
Covered Metallic Stent

scholarly journals Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review

2021 ◽  
Vol 14 ◽  
pp. 175628482110421
Author(s):  
Ghassan El Sayed ◽  
Levente Frim ◽  
Jamie Franklin ◽  
Raymond McCrudden ◽  
Charles Gordon ◽  
...  
Keyword(s):  
Acute Pancreatitis ◽  
Radiofrequency Ablation ◽  
Endoscopic Ultrasound ◽  
Case Reports ◽  
Case Series ◽  
Clinical Success Rate ◽  
Ablation Techniques ◽  
Neuroendocrine Neoplasm ◽  
Efficacy And Safety ◽  
Ultrasound Guided

Background: Insulinoma is the most common neuroendocrine neoplasm of the pancreas, characterised by hypoglycaemic symptoms. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) and ethanol ablation (EUS-EA) are novel methods for treating insulinoma. We aimed to perform a systematic review to assess the efficacy and safety of EUS-guided ablation techniques for pancreatic insulinomas. Methods: We systematically searched for articles detailing EUS-guided ablations of insulinomas. We performed a qualitative analysis and summarised data on the efficacy and safety of EUS-RFA and EUS-EA techniques. Results: In total, we identified 35 case reports and case series describing 75 patients with insulinomas treatment with EUS-guided ablation. Twenty-seven patients were treated with EUS-RFA, 47 patients with EUS-EA, and 1 patient received EUS-EA and EUS-RFA in the same session. In total, 84 insulinomas were ablated (EUS-RFA: 31, EUS-EA: 53). Most insulinomas were in the head of the pancreas (40%). The clinical success rate for EUS-guided ablation techniques was 98.5%. The median glucose level was 1.95 (Q1-Q3: 1.69–2.13) mmol/L before ablation compared to 6.20 (Q1-Q3: 5.30–7.05) mmol/L after treatment. The median insulin and C-peptide levels before and after RFA/EA were 230 (Q1–Q2: 120–257) pmol/L and 41 (Q1–Q2 35–42) pmol/L; 2077 (Q1–Q2 1644–2459) pmol/L and 819 (Q1–Q2 696–1072) pmol/L, respectively. There were eleven adverse events: seven abdominal pain, two mild acute pancreatitis, one necrotising acute pancreatitis and one local hematoma. All patients recovered, and there were no periprocedural deaths. Conclusions: EUS-guided ablation of insulinoma seems to be a safe and effective treatment and is an alternative to surgical resection in selected cases.

Sign in / Sign up

Export Citation Format

Share Document